Navigation Links
Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
Date:5/11/2009

virus infection, some state and county public health authorities now only require confirmatory testing for specimens from certain high risk patients or under certain circumstances.

With the availability of the Focus Diagnostics Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test, physicians will be able to submit patient specimens that are found to be positive for Influenza virus type A through testing performed by a Quest Diagnostics' regional laboratory or other private clinical laboratory to Focus Diagnostics' reference laboratory for novel H1N1 laboratory testing. A physician that believes a patient is at high risk of novel H1N1 infection may order the new Focus Diagnostics test to aid the diagnosis of Influenza virus type A infection, including the novel H1N1 virus. Focus Diagnostics would also submit those test specimens found to be positive as well as the test results to the appropriate public health authorities, as required by local public health guidelines.

"The availability of the new Focus Diagnostics laboratory test will enable physicians and hospitals to quickly identify patients infected with S-OIV and differentiate them from patients infected with other Influenza A strains," said Jay M. Lieberman, M.D., medical director, Focus Diagnostics. "We will continue to aid our public health colleagues in responding to the H1N1 outbreak, and encourage clinicians to follow testing guidelines provided by public health authorities."

Focus Diagnostics has collaborated with the U.S. Centers for Disease Control and Prevention, the World Health Organization and other public health agencies to help identify and develop diagnostic tests for emerging infectious diseases. Focus Diagnostics was instrumental in developing the first laboratory developed test for West Nile Virus after it was identified in New York in 1999. Focus Diagnostics also introduced the first laboratory developed test for SARS and the first FDA-cl
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
2. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
3. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
4. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
5. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
6. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
7. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
8. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
9. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
10. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
11. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... investigating the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... only $158.00 per share. Concerned SLXP investors are encouraged ... . The investigation focuses upon the ... proposed agreement, Salix shareholders would receive only $158.00 per ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... , WASHINGTON, Nov. 4 Sanford Wittels & Heisler, ... AtriCure, Inc., a medical device company specializing in cardiac ... with the Department of Justice (DOJ) in a qui ... interest over a five-year period. , Sanford Wittels & ...
... OAKS, Calif., Nov. 4 Amgen (Nasdaq: AMGN ... its 19th annual Amgen Award for Science Teaching Excellence ... honor extraordinary science teachers at the K-12 level who ... who achieve demonstrated results in student learning in communities ...
Cached Medicine Technology:Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement 2Call for Applications: The Amgen Award for Science Teaching Excellence 2Call for Applications: The Amgen Award for Science Teaching Excellence 3
(Date:2/27/2015)... Hoffman Estates, IL (PRWEB) February 27, 2015 ... could be bad for people’s health. Mercola.com has ... that do not contain toxic flame retardant chemicals. ... with superior product design and better materials. Organic ... All of Dr. Mercola’s organic bedding products are ...
(Date:2/27/2015)... ResearchMoz has announced the addition ... of the cell culture protein surface coating market ... current scenario and development prospects of the global ... period of 2015 to 2019. , Read Complete ... The research report, titled Global Cell Culture Protein ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Philanthropy is a ... and Amy Smits help to restore that faith by ... last six years, this husband/wife Realtor team gives to the ... have remained the same while others have been added as ... provides a safe haven and counseling for women who ...
(Date:2/27/2015)... WA (PRWEB) February 27, 2015 ... health management organizations, has been named a finalist ... Awards in recognition of outstanding commitment toward continuous ... Health’s success in reducing hospital readmission rates through ... , “We are honored to receive this national ...
(Date:2/27/2015)... February 27, 2015 Jvion announced ... is collaborating with the Atlanta-based software company through ... of Jvion’s advanced predictive capabilities suite within the ... that identifies and prevents financial and clinical losses ... predictions that help prevent patient deterioration and suffering, ...
Breaking Medicine News(10 mins):Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 2Health News:Global Cell Culture Protein Surface Coating Industry: Rising Focus towards Stem Cells Research to Trigger Market Growth 3Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:Qualis Health Named Award Finalist for Care Transitions Work 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 3
... Expanded use of electronic medical records would substantially reduce infant ... the Journal of Political Economy. A ... would save 16 babies for every 100,000 live births, the ... save an estimated 6,400 infants each year in the U.S. ...
... May 18, 2011 The American Society for Gastrointestinal ... of its program specifically dedicated to promoting quality in ... the United States. The ASGE Endoscopy Unit Recognition Program ... privileging, quality assurance, endoscopy reprocessing and CDC infection control ...
... A flame retardant banned years ago in many parts of the ... of potentially toxic flame retardants found in baby products such as ... reports. Flame retardants are used to reduce the risk of ... catching fire, and to slow the rate of burning if it ...
... 18 (HealthDay News) -- Deprivation and neglect can cause ... Researchers examined DNA samples collected from institutionalized children ... in a long-term study. Some of the children remained ... foster care at different ages. Children who spent ...
... fast can you run a mile? If you,re middle-aged, the ... attack or stroke over the next decade or more. In ... how fast a middle-age person can run a mile can help ... later for men and could be an early indicator of cardiovascular ...
... survey of hospice care in the United States says that ... care for terminally ill patients raises serious concerns about whose ... of shareholders or those of dying patients and their loved ... an inherent conflict of interest between a company,s drive to ...
Cached Medicine News:Health News:Electronic medical records lower infant mortality, study finds 2Health News:ASGE recognizes 30 endoscopy units for quality and safety 2Health News:ASGE recognizes 30 endoscopy units for quality and safety 3Health News:Potentially Toxic Flame Retardants Found in Baby Products 2Health News:Early Adversity May Shorten Child's Life 2Health News:Simple fitness test could predict long-term risk for heart attack, stroke in middle-aged people 2Health News:Simple fitness test could predict long-term risk for heart attack, stroke in middle-aged people 3Health News:Rise of for-profit hospice industry raises troubling questions, new study says 2
... Flow rate: 80 cc/minute. ... For filtering fluids at ... table; bi-directional membrane support ... (75 psi) via prefilled ...
Non-linting, quick absorption and rounded corners. Tapered malleable handle. Dispenser carton contains 25 envelopes, each envelope contains 10 sponges packaged sterile in Tyvek peel-back pouch....
Rotating 360 degrees, 1.5 mm x 4 mm bite....
Straight, right side cutting, 1.5 mm x 4 mm bite, length of shaft 115 mm, overall length 6.3 inches....
Medicine Products: